Stay updated on SAGE-217 for Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-217 for Severe Postpartum Depression Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 appears in the page footer, replacing Revision: v3.3.1; this is a minor textual update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedPublications section updated to indicate entries are automatically filled from PubMed and may not relate to the study; Revision: v3.3.1 added — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedAdministrative notice about government funding status and operating status was removed from the page. The core study details, eligibility criteria, and related information remain unchanged.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now lists additional participating sites across the United States and abroad, expanding the enrollment locations.SummaryDifference0.3%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference2%

- Check79 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.3%

Stay in the know with updates to SAGE-217 for Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for Severe Postpartum Depression Clinical Trial page.